Lakefront Bio ADR earnings beat by $0.55, revenue fell short of estimates

๐ŸŒ Investing.com (Cyprus) —
Lakefront Bio ADR earnings beat by $0.55, revenue fell short of estimates

AI Summary

Lakefront Bio ADR earnings beat analyst expectations by $0.55, while revenue fell short of estimates. The headline does not provide additional information about results or guidance.

Markets Health Lakefront Bio earnings ADR revenue biotechnology

Read original source →